Shanghai Lei Yun Shang Pharmaceutical Co., Ltd. Sustainability Profile
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd., commonly referred to as Lei Yun Shang, is a prominent player in the pharmaceutical industry, headquartered in Shanghai, China. Established in 1992, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, catering to both domestic and international markets. With a focus on innovative healthcare solutions, Lei Yun Shang offers a diverse range of products, including herbal remedies and prescription medications, distinguished by their quality and efficacy. The company has achieved notable recognition for its commitment to research and development, positioning itself as a leader in the integration of traditional practices with contemporary medical advancements. Through its dedication to excellence, Shanghai Lei Yun Shang continues to enhance its market presence and contribute to the global healthcare landscape.
DitchCarbon Score
How does Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.'s reported carbon emissions
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd., headquartered in China, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., which may influence its climate commitments and reporting practices. As of now, there are no documented reduction targets or climate pledges from Shanghai Lei Yun Shang Pharmaceutical Co., Ltd. This lack of specific initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of the pharmaceutical industry, it is essential for companies like Shanghai Lei Yun Shang to align with broader sustainability goals, particularly in reducing greenhouse gas emissions. The industry is increasingly under pressure to adopt science-based targets and improve transparency in emissions reporting. While no specific emissions data or reduction initiatives are available, the company's affiliation with Shanghai Pharmaceuticals Holding Co., Ltd. may provide a framework for future climate commitments and performance improvements.
How Carbon Intensive is Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.'s Location?
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.